Site Search
Professionals 33 results
Capabilities 30 results
Practice Area
Trade Secrets, Non Competes & Restrictive Covenants
Theft of trade secrets and other confidential information occurs all too frequently in today’s global, highly mobile, and competitive marketplace. In the course of advising clients, we have developed comprehensive, yet scalable, strategies for both mitigating against and responding to issues along the trade secrets protection spectrum, including helping position clients proactively before trade secrets theft occurs.
Practice Area
Environmental, Social & Governance (ESG)
Winston’s Environmental, Social, & Governance (ESG) Advisory Team synthesizes the firm’s multidisciplinary experience to help boards, management teams, and investors oversee the complete spectrum of ESG-related legal and business issues.
Practice Area
Securities, M&A & Corporate Governance Litigation
In today’s market, litigators with experience in securities, corporate governance, and M&A-related (collectively, “securities litigation”) matters need to leverage their broad experience to serve as both advocate and as counsel and strategist, focused on helping clients to overcome not just a legal issue but a collective business problem. Given the frequent interplay between things such as corporate-control transactions, public offerings, activist shareholders, the use of complex derivatives and other financial instruments, bad news impacting stock performance, regulatory inquiries and investigations, and insurance coverage, strategic and tactical litigation decisions can have a wide-ranging impact on the success of a given transaction, as well as on companies, their boards, senior management, and advisors.
Experience 3 results
Experience
|November 9, 2023
Winston advised Grupo Energía Bogotá (GEB) in the first issuance of Sustainability Bonds in Colombia
Experience
|November 7, 2023
Experience
|October 13, 2021
US$1.18B Green Financing for First North American Flood Prevention P3
Insights & News 405 results
Article
|November 21, 2024
|10+ Min Read
How To Safely Leverage AI In The Digital Assets Industry
This article was originally published in Law360. Reprinted with permission. Any opinions in this article are not those of Winston & Strawn or its clients. The opinions in this article are the authors’ opinions only.
Webinar
|November 5, 2024
Decoding AI Law - Fall 2024 Edition
Join Winston’s Artificial Intelligence attorneys throughout November for a CLE-accredited webinar series exploring the latest topics at the intersection of generative and general AI and the law.
Speaking Engagement
|October 29, 2024
Keerthika Subramanian Joins AI Governance Panel to Discuss Legal Challenges and Corporate Solutions
On October 29, 2024, capital markets partner Keerthika Subramanian participated in an AI Governance panel hosted by Carnegie Mellon University's Heinz School of Business as part of its Chief Data and Artificial Intelligence Officer Certificate Program. She was joined by Krishna Cheriath, Chief Data, Analytics, and AI Officer at Thermo Fisher Scientific's Clinical Research Group, and Matt DeVoe, VP and Chief Information Security Officer at Zoetis Inc.
Other Results 22 results
Law Glossary
Privacy Shield is the segment of privacy law that covers compliance with the legal data protection requirements of the European Union (EU) and/or Switzerland. The U.S. has two Privacy Shield Frameworks that American organizations can join. The EU-U.S. Privacy Shield Framework was created by the Department of Commerce and the European Commission, while the Swiss-U.S. Privacy Shield Framework was designed by the Department of Commerce with the Swiss government.
Law Glossary
What Is the Approval Process for Generic Drugs?
Approval for generic drugs are governed by the Hatch-Waxman Act. The Hatch-Waxman Act provides the framework for an applicant to demonstrate that its proposed generic product is bioequivalent to the brand-name drug.
Law Glossary
Colloquially referred to as the “patent dance,” the BPCIA provides a framework that includes certain steps and a schedule during which the applicant and reference product sponsor exchange confidential information disclosed in the aBLA. During the patent dance, the applicant and sponsor identify the patents that could be litigated in the future during two potential phases of litigation. In the first phase, the sponsor can allege infringement of a subset of the patents identified during the patent dance. The second phase begins after the sponsor receives the Notice of Commercial Marketing from the applicant. During this second phase, the sponsor can assert any remaining patents that were not asserted in the first phase.